U.S. Markets close in 4 hrs 22 mins

Mithra Pharmaceuticals SA (MITPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
23.900.00 (0.00%)
As of 2:37PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 324.75
52 Week Low 318.32
50-Day Moving Average 323.90
200-Day Moving Average 323.90

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 542.71M
Implied Shares Outstanding 6N/A
Float 818.48M
% Held by Insiders 143.21%
% Held by Institutions 119.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-926.67%

Management Effectiveness

Return on Assets (ttm)-11.37%
Return on Equity (ttm)-57.37%

Income Statement

Revenue (ttm)9.03M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)-91.50%
Gross Profit (ttm)5.57M
EBITDA -77.94M
Net Income Avi to Common (ttm)-92.09M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)138.69M
Total Cash Per Share (mrq)3.25
Total Debt (mrq)328.64M
Total Debt/Equity (mrq)208.35
Current Ratio (mrq)3.37
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-80.03M
Levered Free Cash Flow (ttm)-111.56M